This can be attributed to existing autocrine GH from the tumor, which could still promote tumoral ABC transporter expression and consequent cisplatin efflux in the GHKO mice but was successfully attenuated in the GHA mice by the circulating GHRA. Here, ABCG2 is linked to neoplasm.